[
  {
    "ts": "2026-01-12T14:00:00+00:00",
    "headline": "Distalmotion Secures Strategic Investment to Advance ASC Expansion of the DEXTER® Robotic Surgery System",
    "summary": "Distalmotion Secures Strategic Investment to Advance ASC Expansion of the DEXTER® Robotic Surgery System Distalmotion, the global MedTech company empowering access to robotic surgery in outpatient sites of care, today announced a strategic investment from Johnson & Johnson, through its corporate venture capital organization, Johnson & Johnson Innovation – JJDC, Inc (“JJDC”). This investment follows the company’s successful 2025 closing of its $150M Series G round, led by Revival Healthcare Capit",
    "url": "https://finance.yahoo.com/news/distalmotion-secures-strategic-investment-advance-140000213.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "40117705-1593-34af-9e23-34d27c33566c",
      "content": {
        "id": "40117705-1593-34af-9e23-34d27c33566c",
        "contentType": "STORY",
        "title": "Distalmotion Secures Strategic Investment to Advance ASC Expansion of the DEXTER® Robotic Surgery System",
        "description": "",
        "summary": "Distalmotion Secures Strategic Investment to Advance ASC Expansion of the DEXTER® Robotic Surgery System Distalmotion, the global MedTech company empowering access to robotic surgery in outpatient sites of care, today announced a strategic investment from Johnson & Johnson, through its corporate venture capital organization, Johnson & Johnson Innovation – JJDC, Inc (“JJDC”). This investment follows the company’s successful 2025 closing of its $150M Series G round, led by Revival Healthcare Capit",
        "pubDate": "2026-01-12T14:00:00Z",
        "displayTime": "2026-01-12T14:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/2a93e7ecb8fa887f8c222dbc9db586a4",
          "originalWidth": 2363,
          "originalHeight": 1772,
          "caption": "Distalmotion, the global MedTech company empowering access to robotic surgery in outpatient sites of care, today announced a strategic investment from Johnson & Johnson, through its corporate venture capital organization, Johnson & Johnson Innovation – JJDC, Inc (“JJDC”).  This investment follows the company’s successful 2025 closing of its $150M Series G round, led by Revival Healthcare Capital. Distalmotion focuses on the growing need for a purpose-built robotic platform designed for Ambulatory Surgery Centers (ASCs).",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XOexlw9RjgLK12OF02xzIA--~B/aD0xNzcyO3c9MjM2MzthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/2a93e7ecb8fa887f8c222dbc9db586a4.cf.webp",
              "width": 2363,
              "height": 1772,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/svomfnZBoHSepBbDV5bTKQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/2a93e7ecb8fa887f8c222dbc9db586a4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/distalmotion-secures-strategic-investment-advance-140000213.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/distalmotion-secures-strategic-investment-advance-140000213.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-12T16:38:00+00:00",
    "headline": "‘Biotech Super Bowl’ Lands With a Thud. Stocks Slide on Lack of Deal News.",
    "summary": "Monday is the first day of  J.P. Morgan’s  annual healthcare investor conference, which draws thousands of investors, analysts, and executives to San Francisco each year.  There is ample precedent: Last year,  Johnson & Johnson  announced a $14.6 billion deal to acquire Intra-Cellular Therapeutics on the first day of the gathering.  The Wall Street Journal reported last week that Merck was in talks to buy the biotech Revolution Medicines for roughly $30 billion, but as of late morning, no such agreement had been announced.",
    "url": "https://www.barrons.com/articles/biotech-stocks-chase-conference-b9cab762?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "b75019f7-5087-30b3-a925-6f9de1cc8a35",
      "content": {
        "id": "b75019f7-5087-30b3-a925-6f9de1cc8a35",
        "contentType": "STORY",
        "title": "‘Biotech Super Bowl’ Lands With a Thud. Stocks Slide on Lack of Deal News.",
        "description": "",
        "summary": "Monday is the first day of  J.P. Morgan’s  annual healthcare investor conference, which draws thousands of investors, analysts, and executives to San Francisco each year.  There is ample precedent: Last year,  Johnson & Johnson  announced a $14.6 billion deal to acquire Intra-Cellular Therapeutics on the first day of the gathering.  The Wall Street Journal reported last week that Merck was in talks to buy the biotech Revolution Medicines for roughly $30 billion, but as of late morning, no such agreement had been announced.",
        "pubDate": "2026-01-12T16:38:00Z",
        "displayTime": "2026-01-12T16:38:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/b75019f7-5087-30b3-a925-6f9de1cc8a35/%E2%80%98biotech-super-bowl%E2%80%99-lands.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/8ebdb690c83f7dcd8efc0f89134f191d",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BHJPDjWZKaPfXg5a3nUTWQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/8ebdb690c83f7dcd8efc0f89134f191d.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qa7w9DeR_tRxUp5wVzRzPw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/8ebdb690c83f7dcd8efc0f89134f191d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/biotech-stocks-chase-conference-b9cab762?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "XBI"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "JPM"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]